Steven Denbaars is Director at Akoustis Technologies, Inc. (AKTS). They have made 14 open-market trades across 3 companies since 2018, most recently 2026-08-27.
CIK 0001700533
3 open-market purchases totalling $350K since 2021, against 11 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| AKTS | 325,959 | $4.9M |
| ALMU | 345,209 | $2.8M |
| SMTK | 815 | $427 |
| PrivateUnlisted | 1,762,500 | — |
| Total | $7.7M |
Shares reported on the most recent Form 4, priced at the 2026-08-28 close. 1 holding could not be priced and is excluded from the total.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ALMU | SELL | 2026-08-26 | 2026-08-28 | $13.83 | $346K | +1.3% | -2.7% | — |
| ALMU | SELL · 10b5-1 | 2026-05-19 | 2026-05-21 | $20.23 | $506K | +14.8% | +0.0% | -34.0% |
| PrivatePalomino Laboratories Inc. | BUY | 2026-04-20 | 2026-04-20 | $4.00 | $50K | N/A | N/A | N/A |
| ALMU | SELL · 10b5-1 | 2026-02-25 | 2026-02-27 | $16.72 | $418K | -0.1% | -21.3% | +43.4% |
| AKTS | SELL · 10b5-1 | 2023-08-18 | 2023-08-22 | $1.83 | $13K | -16.0% | -57.3% | -66.9% |
| AKTS | SELL · 10b5-1 | 2022-12-06 | 2022-12-08 | $3.57 | $25K | -19.4% | -13.1% | +9.4% |
| AKTS | SELL · 10b5-1 | 2022-09-06 | 2022-09-08 | $3.90 | $27K | -17.4% | -39.8% | -18.1% |
| AKTS | SELL · 10b5-1 | 2022-06-06 | 2022-06-07 | $4.48 | $31K | -19.3% | -17.4% | -12.2% |
| AKTS | SELL · 10b5-1 | 2022-01-11 | 2022-01-13 | $5.91 | $41K | -14.9% | -13.4% | -7.9% |
| ALMU | BUY | 2021-12-22 | 2025-05-23 | $3.00 | $100K | +27.8% | -8.2% | +32.6% |
| AKTS | SELL | 2021-10-11 | 2021-10-13 | $8.08 | $57K | -14.7% | -9.1% | -30.5% |
| AKTS | SELL | 2021-07-12 | 2021-07-13 | $9.93 | $70K | -3.9% | -7.6% | -19.2% |
| PrivateAeluma, Inc. | BUY | 2021-06-22 | 2021-06-24 | $2.00 | $200K | N/A | N/A | N/A |
| AKTS | SELL | 2021-04-12 | 2021-04-14 | $12.00 | $84K | +1.0% | -29.6% | -19.8% |
| AKTS | SELL | 2021-01-11 | 2021-01-12 | $13.40 | $94K | +29.3% | +25.3% | -9.2% |
| AKTS | SELL | 2020-10-12 | 2020-10-14 | $8.53 | $119K | -1.7% | -2.3% | +64.4% |
| AKTS | SELL | 2020-06-01 | 2020-06-03 | $7.68 | $54K | -0.5% | +7.4% | +3.6% |
| AKTS | SELL | 2020-04-13 | 2020-04-15 | $7.59 | $53K | +10.3% | -1.8% | -0.6% |
| AKTS | SELL | 2020-01-06 | 2020-01-06 | $8.11 | $114K | +8.3% | -6.9% | -40.4% |
| AKTS | SELL | 2019-10-07 | 2019-10-08 | $7.72 | $54K | +2.3% | -12.8% | +1.8% |
| AKTS | SELL · 10b5-1 | 2019-07-08 | 2019-07-10 | $5.63 | $39K | -6.9% | -10.8% | +28.2% |
| AKTS | SELL · 10b5-1 | 2019-04-29 | 2019-05-01 | $6.58 | $46K | +39.1% | +8.9% | -8.3% |
| AKTS | SELL | 2018-03-15 | 2018-03-19 | $6.14 | $224K | -9.3% | -17.4% | +0.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.